2012 Global Immunoprotein Testing Market Outlook: Growth Opportunities and Strategies
US$ 6,000.00
During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and ... and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective ...
April 2012
297 pages
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 22,800.00
... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...
April 2012
1200 pages
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
570 pages
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 5,360.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2012
590 pages
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
565 pages
2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
620 pages
China's Pharmaceutical Industry 2011
US$ 600.00
This report describes the general development of China’s pharmaceutical industry in aspects of investment, production, sales, import & export, major prices and operations.
April 2012
15 pages
Smoking Cessation Drugs: World Market Prospects 2012-2022
US$ 2,633.00
... . R&D is promising. New formulations and generics will be important too. Innovations in drug delivery and rising demand in developing countries will also stimulate ... , 29 charts and three research interviews. Eight ways Smoking Cessation Drugs: World Market Prospects 2012-2022 helps you In particular, our ...
April 2012
116 pages
Merck - Celltrion filed first mAB Biosimilar in Europe: Remicade Challenged
US$ 90.00
Celltrion filed infliximab biosimilar (CT-P13) in Europe and was accepted for review by EMA. It is the first biosimilar mAb to be filed for approval in Europe. The patent ... Celltrion conducted PhI and PhIII clinical trials with the duration of 12 months in more than 850 patients. It has already filed Infliximab ...
April 2012
1 pages
Medicated Skin Care in Hong Kong, China
US$ 990.00
... occurrences of skin diseases or symptoms in Hong Kong will continue to see growth in medicated skin care due to stressful lifestyle, diseases, erratic weather conditions, etc. Euromonitor International's Medicated Skin Care in Hong Kong, China ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
20 pages
Clinical Trials Market in India 2012
US$ 950.00
... into the market and highlights the market size and growth of clinical trials in the country. India’s current and projected share in the global clinical trials market has also ...
April 2012
58 pages
Medicated Skin Care in Ecuador
US$ 990.00
... any measures to prevent the consequences. This has... Euromonitor International's Medicated Skin Care in Ecuador report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
22 pages
Emergency Contraception in Belarus
US$ 990.00
... be used under medical supervision. Most of the hormonal contraceptive medicines in Belarus are Rx products. Euromonitor International's Emergency Contraception in Belarus report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2012
19 pages
Medicated Skin Care in Belarus
US$ 990.00
... . Rising urban population and stress levels in Belarus also resulted in an increase in the incidence of skin... Euromonitor International's Medicated Skin Care in Belarus report offers a comprehensive guide to the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
35 pages
NRT Smoking Cessation Aids in Belarus
US$ 990.00
... to lower the smoking rate. Heart disease accounts for some 88% of deaths from smoking-related illnesses in Belarus. Other... Euromonitor International's NRT Smoking Cessation Aids in Belarus report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
April 2012
24 pages
Weight Management in Belarus
US$ 900.00
... to obesity products, which are only available in... Euromonitor International's Weight Management in Belarus report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the Weight Management market; Pinpoint growth sectors and identify factors driving ...
April 2012
23 pages
Medicated Skin Care in Turkey
US$ 990.00
... are usually cosmetic products rather than medicines. Euromonitor International's Medicated Skin Care in Turkey report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
28 pages
Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
US$ 3,700.00
... to Susan Eustis, lead author of the study, 'Reimbursement drives power wheelchair markets'. As people and governments pay for medical insurance more money ... , permitting the patient to control mobility for the rehabilitation efforts. Power wheel chairs give patients the ability to control movement. Transport ...
April 2012
467 pages
REGENERON: Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!
US$ 90.00
... with Bayer for Ex-US, wet AMD) launch skyrocketed Regeneron (REGN); we expect other TRAP based products in the pipeline to sustain this ... Sanofi granted A Priority Review for ZALTRAP (VEGF trap/ aflibercept, R, mCRC – 2nd-line; PhII/ ... 5, 2012 on REGN, titled “Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!”
April 2012
5 pages
Medicated Skin Care in France
US$ 990.00
... drugs and Rx medicines because they are reimbursed. Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
42 pages
New Product Developments in Consumer Health
US$ 2,000.00
... exploring new delivery mechanisms and formulas to stand out. Euromonitor International’s New Product Developments in Consumer Health global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of ...
April 2012
43 pages
Medicated Skin Care in the US
US$ 990.00
... diapers, which increases the incidence of diaper rash. Euromonitor International's Medicated Skin Care in USA report offers a comprehensive guide to the size and shape ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
53 pages
Healthcare Industry Deal Directory - Edition Q4'2011
US$ 350.00
The healthcare database provides access to all the Mergers and Acquisitions (M&A), Private Equity and Venture Capital Deals since 2004. The database is categorized into various sub-sectors includi...
April 2012
Computed Tomography (CT) Systems: Global Market Outlook 2012-2022
US$ 2,635.00
... review of companies and leading products. Why you should buy Computed Tomography (CT) Systems: Global Market Outlook 2012-2022 In this report, you ... the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the CT systems market from 2012 onwards You will be able to investigate competition ...
April 2012
117 pages
U.S. Market for Gastrointestinal Endoscopic Devices 2012
US$ 7,495.00
... will result in growth returning to pre-recession levels by 2018. Within the gastrointestinal endoscopic device market, companies such as Boston Scientific, Cook Medical, Given Imaging, Olympus and Pentax lead the market, among many others. This report provides a comprehensive and detailed analysis ...
April 2012
457 pages
Asia Pacific Markets for Women’s Health Devices 2012
US$ 8,495.00
In 2011, the total market for the Asia-Pacific women’s health devices was valued at over $790 million. The main conditions dealt ... Japan Australia. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, ...
April 2012
596 pages
Asia-Pacific Markets for Vascular Access Devices and Accessories 2012 (3 Countries)
US$ 7,495.00
The vascular access devices market in the Asia-Pacific region encompass implantable ports, port needles, central venous catheters, ... intravenous catheters. The Asia-Pacific vascular access devices market report analyzes and evaluates the current state of the market including existing and potential markets, product average ...
April 2012
205 pages
